Biosimilars Market By Type (Protein, Insulin, Human Growth Hormones, Granulocyte Colony-stimulating Factor (G-CSF), Interferons, Recombinant Glycosylated Proteins, Erythropoietin, Monoclonal Antibodies, Follitropin, Recombinant Peptides, Glucagon, Calcitonin), By Technology (, Mass Spectroscopy, Chromatography And Others), By Application (Oncology And Blood Diseases, Growth Hormone Deficiencies And Others), By Region - Global Growth, Trends, And Forecasts 2018-2023

Biosimilars Market By Type (Protein, Insulin, Human Growth Hormones, Granulocyte Colony-stimulating Factor (G-CSF), Interferons, Recombinant Glycosylated Proteins, Erythropoietin, Monoclonal Antibodies, Follitropin, Recombinant Peptides, Glucagon, Calcitonin), By Technology (, Mass Spectroscopy, Chromatography And Others), By Application (Oncology And Blood Diseases, Growth Hormone Deficiencies And Others), By Region - Global Growth, Trends, And Forecasts 2018-2023

ID: 1142 | Pages: 175 | October 2018 | Region: Global


Biosimilars Market Overview

Biosimilars are emerging as one of the most important sectors in the healthcare industry. With increasing healthcare costs, biosimilars are being looked upon as an affordable treatment option. Growing economies are observing comprehensive growth in biosimilars industry from demanding clinical needs of therapeutics. Rise in GDP and healthcare expenditures, and the demand for cost-effective therapeutics solution has resulted in the growth of this market.

Biosimilars are made using living cells that treat disease, by recombinant DNA technology and controlled gene expression. Most biosimilars are derived from bacteria, viruses, plants, and animals. Biosimilar drugs are used in prevention and cure of various diseases such as rheumatoid arthritis, cancer, chronic kidney failure, oncology, diabetes, heart attacks, autoimmune diseases, growth hormone deficiency, and infectious disease.

Biosimilars offer a cheaper alternative for other biological and synthetic drugs. Across the world, the biosimilars market is driven by an aging population and increasing rates of diabetes and chronic disorders. Government support and initiatives play a crucial role. Emerging pharmaceutical markets and lenient government regulations provide some of the major openings this is market. In addition, increased co-operation between manufacturing companies, and the outsourcing of biosimilar products are acting as an impetus for the biosimilars market. However, high manufacturing cost and complexity, and the availability of low priced generic drugs in the market are some of the major restraints of the biosimilars market are facing.

Biosimilars  Market Forecast Report (2018-2023)

Biosimilars Market was worth USD 7.66 million in 2018 and estimated to be growing at a CAGR of 26.87%, to reach USD 25.18 million by 2023.

Biosimilars Market Segmentation

Based on product types, biosimilars are classified into Protein, Insulin, Human Growth Hormones, Granulocyte Colony-stimulating Factor (G-CSF), Interferons, Recombinant Glycosylated Proteins, Erythropoietin, Monoclonal Antibodies, Follitropin, Recombinant Peptides, Glucagon and Calcitonin. By application, they have been segemented into chronic and autoimmune diseases, blood disorders, oncology and growth hormone deficiency. Furthermore, based on geography the market is segmented into various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. Europe is undoubtedly the largest market, followed by North America and Asia-Pacific regions. India and China are estimated to grow the fastest. Other countries such as the U.S., Brazil and South Korea, are also expected to record high growth over the next five years.

Key Developments in the Market

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it has initiated the commercial launch of Hulio™, a biosimilar to AbbVie's Humira® (adalimumab), across major markets in Europe.

Major Players: 

Some of the major players in the biosimilars market are

  • Sandoz International GmbH,
  • Wockhardt Ltd, Hospira, Inc.,
  • Teva Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories,
  • Biocon Limited,
  • Mylan, Inc.,
  • Zydus Cadila,
  • Celltrion Inc.,
  • Roche Diagnostics
  • Cipla Ltd.

Reasons to Purchase Biosimilars Market Report

  • Market analysis of the globally Biosimilars market, with region-specific assessments and competition analysis on a global and regional scale
  • Analyze various perspectives of the industry with the help of Porter’s five forces analysis
  • The treatment type that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3 months of analyst support, along with the Market Estimate sheet (in excel)

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Protein     

                                5.1.2 Insulin       

                                5.1.3 Human Growth Hormones

                                5.1.4 Granulocyte Colony-stimulating Factor (G-CSF)       

                                5.1.5 Interferons             

                                5.1.6 Recombinant Glycosylated Proteins             

                                5.1.7 Erythropoietin       

                                5.1.8 Monoclonal Antibodies     

                                5.1.9 Follitropin

                                5.1.10 Recombinant Peptides    

                                5.1.11 Glucagon               

                                5.1.12 Calcitonin              

                5.2 By Technology                          

                                5.2.1 Mass Spectroscopy             

                                5.2.2 Chromatography  

                                5.2.3 Monoclonal Antibody Technology

                                5.2.4 Recombinant DNA Technology       

                                5.2.5 Nuclear magnetic resonance (NMR) technology     

                                5.2.6 Electrophoresis     

                                5.2.7 Bioassay   

                5.3 By Application                           

                                5.3.1 Oncology diseases

                                5.3.2 Blood disorders    

                                5.3.3 Growth hormone deficiencies        

                                5.3.4 Chronic and autoimmune diseases

                                5.3.5 Others      

6. Geographical Analysis                                              

                6.1 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.2 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy           

                                6.2.6 France      

                6.3 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan        

                                6.3.5 South Korea           

                                6.3.6 Australia  

                6.4 Latin America                            

                                6.4.1 Introduction           

                                6.4.2 Brazil         

                                6.4.3 Argentina

                                6.4.4 Mexico     

                6.5 Middle East & Africa               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa        

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Sandoz International GmbH                

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Wockhardt                 

                8.3 Hospira                        

                8.4 Teva Pharmaceutical Industries                         

                8.5 Dr. Reddy’s Laboratories                      

                8.6 Biocon                          

                8.7 Mylan                           

                8.8 Zydus Cadila                               

                8.9 Celltrion                       

                8.10 Roche Diagnostics                 

                8.11 Cipla                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

                                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Global Biosimilars Market By Region, From 2018-2023 ( USD Million )
  2. Global Biosimilars Market By Type, From 2018-2023 ( USD Million )
  3. Global Protein Market By Region, From 2018-2023 ( USD Million )
  4. Global Insulin Market By Region, From 2018-2023 ( USD Million )
  5. Global Human Growth Hormones Market By Region, From 2018-2023 ( USD Million )
  6. Global Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2018-2023 ( USD Million )
  7. Global Interferons Market By Region, From 2018-2023 ( USD Million )
  8. Global Recombinant Glycosylated Proteins Market By Region, From 2018-2023 ( USD Million )
  9. Global Erythropoietin Market By Region, From 2018-2023 ( USD Million )
  10. Global Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  11. Global Follitropin Market By Region, From 2018-2023 ( USD Million )
  12. Global Recombinant Peptides Market By Region, From 2018-2023 ( USD Million )
  13. Global Glucagon Market By Region, From 2018-2023 ( USD Million )
  14. Global Calcitonin Market By Region, From 2018-2023 ( USD Million )
  15. Global Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  16. Global Mass Spectroscopy Market By Region, From 2018-2023 ( USD Million )
  17. Global Chromatography Market By Region, From 2018-2023 ( USD Million )
  18. Global Monoclonal Antibody Technology Market By Region, From 2018-2023 ( USD Million )
  19. Global Recombinant DNA Technology Market By Region, From 2018-2023 ( USD Million )
  20. Global Nuclear magnetic resonance (NMR) technology Market By Region, From 2018-2023 ( USD Million )
  21. Global Electrophoresis Market By Region, From 2018-2023 ( USD Million )
  22. Global Bioassay Market By Region, From 2018-2023 ( USD Million )
  23. Global Biosimilars Market By Application, From 2018-2023 ( USD Million )
  24. Global Oncology diseases Market By Region, From 2018-2023 ( USD Million )
  25. Global Blood disorders Market By Region, From 2018-2023 ( USD Million )
  26. Global Growth hormone deficiencies Market By Region, From 2018-2023 ( USD Million )
  27. Global Chronic and autoimmune diseases Market By Region, From 2018-2023 ( USD Million )
  28. Global Others Market By Region, From 2018-2023 ( USD Million )
  29. North America Biosimilars Market By Type, From 2018-2023 ( USD Million )
  30. North America Protein Market By Region, From 2018-2023 ( USD Million )
  31. North America Insulin Market By Region, From 2018-2023 ( USD Million )
  32. North America Human Growth Hormones Market By Region, From 2018-2023 ( USD Million )
  33. North America Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2018-2023 ( USD Million )
  34. North America Interferons Market By Region, From 2018-2023 ( USD Million )
  35. North America Recombinant Glycosylated Proteins Market By Region, From 2018-2023 ( USD Million )
  36. North America Erythropoietin Market By Region, From 2018-2023 ( USD Million )
  37. North America Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  38. North America Follitropin Market By Region, From 2018-2023 ( USD Million )
  39. North America Recombinant Peptides Market By Region, From 2018-2023 ( USD Million )
  40. North America Glucagon Market By Region, From 2018-2023 ( USD Million )
  41. North America Calcitonin Market By Region, From 2018-2023 ( USD Million )
  42. North America Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  43. North America Mass Spectroscopy Market By Region, From 2018-2023 ( USD Million )
  44. North America Chromatography Market By Region, From 2018-2023 ( USD Million )
  45. North America Monoclonal Antibody Technology Market By Region, From 2018-2023 ( USD Million )
  46. North America Recombinant DNA Technology Market By Region, From 2018-2023 ( USD Million )
  47. North America Nuclear magnetic resonance (NMR) technology Market By Region, From 2018-2023 ( USD Million )
  48. North America Electrophoresis Market By Region, From 2018-2023 ( USD Million )
  49. North America Bioassay Market By Region, From 2018-2023 ( USD Million )
  50. North America Biosimilars Market By Application, From 2018-2023 ( USD Million )
  51. North America Oncology diseases Market By Region, From 2018-2023 ( USD Million )
  52. North America Blood disorders Market By Region, From 2018-2023 ( USD Million )
  53. North America Growth hormone deficiencies Market By Region, From 2018-2023 ( USD Million )
  54. North America Chronic and autoimmune diseases Market By Region, From 2018-2023 ( USD Million )
  55. North America Others Market By Region, From 2018-2023 ( USD Million )
  56. United States Biosimilars Market By Type, From 2018-2023 ( USD Million )
  57. United States Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  58. United States Biosimilars Market By Application, From 2018-2023 ( USD Million )
  59. Canada Biosimilars Market By Type, From 2018-2023 ( USD Million )
  60. Canada Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  61. Canada Biosimilars Market By Application, From 2018-2023 ( USD Million )
  62. Europe Biosimilars Market By Type, From 2018-2023 ( USD Million )
  63. Europe Protein Market By Region, From 2018-2023 ( USD Million )
  64. Europe Insulin Market By Region, From 2018-2023 ( USD Million )
  65. Europe Human Growth Hormones Market By Region, From 2018-2023 ( USD Million )
  66. Europe Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2018-2023 ( USD Million )
  67. Europe Interferons Market By Region, From 2018-2023 ( USD Million )
  68. Europe Recombinant Glycosylated Proteins Market By Region, From 2018-2023 ( USD Million )
  69. Europe Erythropoietin Market By Region, From 2018-2023 ( USD Million )
  70. Europe Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  71. Europe Follitropin Market By Region, From 2018-2023 ( USD Million )
  72. Europe Recombinant Peptides Market By Region, From 2018-2023 ( USD Million )
  73. Europe Glucagon Market By Region, From 2018-2023 ( USD Million )
  74. Europe Calcitonin Market By Region, From 2018-2023 ( USD Million )
  75. Europe Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  76. Europe Mass Spectroscopy Market By Region, From 2018-2023 ( USD Million )
  77. Europe Chromatography Market By Region, From 2018-2023 ( USD Million )
  78. Europe Monoclonal Antibody Technology Market By Region, From 2018-2023 ( USD Million )
  79. Europe Recombinant DNA Technology Market By Region, From 2018-2023 ( USD Million )
  80. Europe Nuclear magnetic resonance (NMR) technology Market By Region, From 2018-2023 ( USD Million )
  81. Europe Electrophoresis Market By Region, From 2018-2023 ( USD Million )
  82. Europe Bioassay Market By Region, From 2018-2023 ( USD Million )
  83. Europe Biosimilars Market By Application, From 2018-2023 ( USD Million )
  84. Europe Oncology diseases Market By Region, From 2018-2023 ( USD Million )
  85. Europe Blood disorders Market By Region, From 2018-2023 ( USD Million )
  86. Europe Growth hormone deficiencies Market By Region, From 2018-2023 ( USD Million )
  87. Europe Chronic and autoimmune diseases Market By Region, From 2018-2023 ( USD Million )
  88. Europe Others Market By Region, From 2018-2023 ( USD Million )
  89. U.K. Biosimilars Market By Type, From 2018-2023 ( USD Million )
  90. U.K. Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  91. U.K. Biosimilars Market By Application, From 2018-2023 ( USD Million )
  92. Germany Biosimilars Market By Type, From 2018-2023 ( USD Million )
  93. Germany Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  94. Germany Biosimilars Market By Application, From 2018-2023 ( USD Million )
  95. France Biosimilars Market By Type, From 2018-2023 ( USD Million )
  96. France Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  97. France Biosimilars Market By Application, From 2018-2023 ( USD Million )
  98. Italy Biosimilars Market By Type, From 2018-2023 ( USD Million )
  99. Italy Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  100. Italy Biosimilars Market By Application, From 2018-2023 ( USD Million )
  101. Spain Biosimilars Market By Type, From 2018-2023 ( USD Million )
  102. Spain Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  103. Spain Biosimilars Market By Application, From 2018-2023 ( USD Million )
  104. Asia-Pacific Biosimilars Market By Type, From 2018-2023 ( USD Million )
  105. Asia-Pacific Protein Market By Region, From 2018-2023 ( USD Million )
  106. Asia-Pacific Insulin Market By Region, From 2018-2023 ( USD Million )
  107. Asia-Pacific Human Growth Hormones Market By Region, From 2018-2023 ( USD Million )
  108. Asia-Pacific Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2018-2023 ( USD Million )
  109. Asia-Pacific Interferons Market By Region, From 2018-2023 ( USD Million )
  110. Asia-Pacific Recombinant Glycosylated Proteins Market By Region, From 2018-2023 ( USD Million )
  111. Asia-Pacific Erythropoietin Market By Region, From 2018-2023 ( USD Million )
  112. Asia-Pacific Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  113. Asia-Pacific Follitropin Market By Region, From 2018-2023 ( USD Million )
  114. Asia-Pacific Recombinant Peptides Market By Region, From 2018-2023 ( USD Million )
  115. Asia-Pacific Glucagon Market By Region, From 2018-2023 ( USD Million )
  116. Asia-Pacific Calcitonin Market By Region, From 2018-2023 ( USD Million )
  117. Asia-Pacific Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  118. Asia-Pacific Mass Spectroscopy Market By Region, From 2018-2023 ( USD Million )
  119. Asia-Pacific Chromatography Market By Region, From 2018-2023 ( USD Million )
  120. Asia-Pacific Monoclonal Antibody Technology Market By Region, From 2018-2023 ( USD Million )
  121. Asia-Pacific Recombinant DNA Technology Market By Region, From 2018-2023 ( USD Million )
  122. Asia-Pacific Nuclear magnetic resonance (NMR) technology Market By Region, From 2018-2023 ( USD Million )
  123. Asia-Pacific Electrophoresis Market By Region, From 2018-2023 ( USD Million )
  124. Asia-Pacific Bioassay Market By Region, From 2018-2023 ( USD Million )
  125. Asia-Pacific Biosimilars Market By Application, From 2018-2023 ( USD Million )
  126. Asia-Pacific Oncology diseases Market By Region, From 2018-2023 ( USD Million )
  127. Asia-Pacific Blood disorders Market By Region, From 2018-2023 ( USD Million )
  128. Asia-Pacific Growth hormone deficiencies Market By Region, From 2018-2023 ( USD Million )
  129. Asia-Pacific Chronic and autoimmune diseases Market By Region, From 2018-2023 ( USD Million )
  130. Asia-Pacific Others Market By Region, From 2018-2023 ( USD Million )
  131. Japan Biosimilars Market By Type, From 2018-2023 ( USD Million )
  132. Japan Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  133. Japan Biosimilars Market By Application, From 2018-2023 ( USD Million )
  134. China Biosimilars Market By Type, From 2018-2023 ( USD Million )
  135. China Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  136. China Biosimilars Market By Application, From 2018-2023 ( USD Million )
  137. India Biosimilars Market By Type, From 2018-2023 ( USD Million )
  138. India Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  139. India Biosimilars Market By Application, From 2018-2023 ( USD Million )
  140. Latin America Biosimilars Market By Type, From 2018-2023 ( USD Million )
  141. Latin America Protein Market By Region, From 2018-2023 ( USD Million )
  142. Latin America Insulin Market By Region, From 2018-2023 ( USD Million )
  143. Latin America Human Growth Hormones Market By Region, From 2018-2023 ( USD Million )
  144. Latin America Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2018-2023 ( USD Million )
  145. Latin America Interferons Market By Region, From 2018-2023 ( USD Million )
  146. Latin America Recombinant Glycosylated Proteins Market By Region, From 2018-2023 ( USD Million )
  147. Latin America Erythropoietin Market By Region, From 2018-2023 ( USD Million )
  148. Latin America Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  149. Latin America Follitropin Market By Region, From 2018-2023 ( USD Million )
  150. Latin America Recombinant Peptides Market By Region, From 2018-2023 ( USD Million )
  151. Latin America Glucagon Market By Region, From 2018-2023 ( USD Million )
  152. Latin America Calcitonin Market By Region, From 2018-2023 ( USD Million )
  153. Latin America Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  154. Latin America Mass Spectroscopy Market By Region, From 2018-2023 ( USD Million )
  155. Latin America Chromatography Market By Region, From 2018-2023 ( USD Million )
  156. Latin America Monoclonal Antibody Technology Market By Region, From 2018-2023 ( USD Million )
  157. Latin America Recombinant DNA Technology Market By Region, From 2018-2023 ( USD Million )
  158. Latin America Nuclear magnetic resonance (NMR) technology Market By Region, From 2018-2023 ( USD Million )
  159. Latin America Electrophoresis Market By Region, From 2018-2023 ( USD Million )
  160. Latin America Bioassay Market By Region, From 2018-2023 ( USD Million )
  161. Latin America Biosimilars Market By Application, From 2018-2023 ( USD Million )
  162. Latin America Oncology diseases Market By Region, From 2018-2023 ( USD Million )
  163. Latin America Blood disorders Market By Region, From 2018-2023 ( USD Million )
  164. Latin America Growth hormone deficiencies Market By Region, From 2018-2023 ( USD Million )
  165. Latin America Chronic and autoimmune diseases Market By Region, From 2018-2023 ( USD Million )
  166. Latin America Others Market By Region, From 2018-2023 ( USD Million )
  167. Brazil Biosimilars Market By Type, From 2018-2023 ( USD Million )
  168. Brazil Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  169. Brazil Biosimilars Market By Application, From 2018-2023 ( USD Million )
  170. Rest of Latin America Biosimilars Market By Type, From 2018-2023 ( USD Million )
  171. Rest of Latin America Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  172. Rest of Latin America Biosimilars Market By Application, From 2018-2023 ( USD Million )
  173. Middle East & Africa Biosimilars Market By Type, From 2018-2023 ( USD Million )
  174. Middle East & Africa Protein Market By Region, From 2018-2023 ( USD Million )
  175. Middle East & Africa Insulin Market By Region, From 2018-2023 ( USD Million )
  176. Middle East & Africa Human Growth Hormones Market By Region, From 2018-2023 ( USD Million )
  177. Middle East & Africa Granulocyte Colony-stimulating Factor (G-CSF) Market By Region, From 2018-2023 ( USD Million )
  178. Middle East & Africa Interferons Market By Region, From 2018-2023 ( USD Million )
  179. Middle East & Africa Recombinant Glycosylated Proteins Market By Region, From 2018-2023 ( USD Million )
  180. Middle East & Africa Erythropoietin Market By Region, From 2018-2023 ( USD Million )
  181. Middle East & Africa Monoclonal Antibodies Market By Region, From 2018-2023 ( USD Million )
  182. Middle East & Africa Follitropin Market By Region, From 2018-2023 ( USD Million )
  183. Middle East & Africa Recombinant Peptides Market By Region, From 2018-2023 ( USD Million )
  184. Middle East & Africa Glucagon Market By Region, From 2018-2023 ( USD Million )
  185. Middle East & Africa Calcitonin Market By Region, From 2018-2023 ( USD Million )
  186. Middle East & Africa Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  187. Middle East & Africa Mass Spectroscopy Market By Region, From 2018-2023 ( USD Million )
  188. Middle East & Africa Chromatography Market By Region, From 2018-2023 ( USD Million )
  189. Middle East & Africa Monoclonal Antibody Technology Market By Region, From 2018-2023 (USD Million)
  190. Middle East & Africa Recombinant DNA Technology Market By Region, From 2018-2023 ( USD Million )
  191. Middle East & Africa Nuclear magnetic resonance (NMR) technology Market By Region, From 2018-2023 ( USD Million )
  192. Middle East & Africa Electrophoresis Market By Region, From 2018-2023 ( USD Million )
  193. Middle East & Africa Bioassay Market By Region, From 2018-2023 ( USD Million )
  194. Middle East & Africa Biosimilars Market By Application, From 2018-2023 ( USD Million )
  195. Middle East & Africa Oncology diseases Market By Region, From 2018-2023 ( USD Million )
  196. Middle East & Africa Blood disorders Market By Region, From 2018-2023 ( USD Million )
  197. Middle East & Africa Growth hormone deficiencies Market By Region, From 2018-2023 ( USD Million )
  198. Middle East & Africa Chronic and autoimmune diseases Market By Region, From 2018-2023 ( USD Million )
  199. Middle East & Africa Others Market By Region, From 2018-2023 ( USD Million )
  200. Middle East Biosimilars Market By Type, From 2018-2023 ( USD Million )
  201. Middle East Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  202. Middle East Biosimilars Market By Application, From 2018-2023 ( USD Million )
  203. Africa Biosimilars Market By Type, From 2018-2023 ( USD Million )
  204. Africa Biosimilars Market By Technology, From 2018-2023 ( USD Million )
  205. Africa Biosimilars Market By Application, From 2018-2023 ( USD Million )
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.